Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elevance Health, Inc. stock logo
ELV
Elevance Health
$394.40
+1.1%
$415.92
$274.84
▼
$450.69
$96.42B0.631.43 million shs2.04 million shs
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$1.32
+1.9%
$1.65
$0.96
▼
$3.03
$105.10M1.52353,366 shs711,626 shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$53.98
-9.5%
$72.79
$40.77
▼
$89.09
$11.81B3.616.43 million shs7.41 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elevance Health, Inc. stock logo
ELV
Elevance Health
+0.90%-8.17%-9.39%-1.56%+24.48%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
+1.94%-12.91%-24.43%-14.05%-37.68%
Tempus AI, Inc. stock logo
TEM
Tempus AI
-9.45%-24.61%-20.34%-25.74%-21.88%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elevance Health, Inc. stock logo
ELV
Elevance Health
$394.40
+1.1%
$415.92
$274.84
▼
$450.69
$96.42B0.631.43 million shs2.04 million shs
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$1.32
+1.9%
$1.65
$0.96
▼
$3.03
$105.10M1.52353,366 shs711,626 shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$53.98
-9.5%
$72.79
$40.77
▼
$89.09
$11.81B3.616.43 million shs7.41 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elevance Health, Inc. stock logo
ELV
Elevance Health
+0.90%-8.17%-9.39%-1.56%+24.48%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
+1.94%-12.91%-24.43%-14.05%-37.68%
Tempus AI, Inc. stock logo
TEM
Tempus AI
-9.45%-24.61%-20.34%-25.74%-21.88%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.70
Moderate Buy$458.9116.36% Upside
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1.83
Reduce$2.0152.72% Upside
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.45
Hold$79.3747.04% Upside

Current Analyst Ratings Breakdown

Latest TEM, HCAT, and ELV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/19/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Reiterated RatingBuy$85.00
11/18/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
UpgradeHold ➝ Buy$510.00
11/11/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Reiterated RatingHold (C)
11/3/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Boost Price TargetBuy$80.00 ➝ $100.00
11/3/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
UpgradeUnderperform ➝ Hold$35.00 ➝ $70.00
11/3/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Boost Price TargetOverweight$80.00 ➝ $92.00
11/3/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Boost Price TargetOutperform$85.00 ➝ $92.00
11/3/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Boost Price TargetBuy$68.00 ➝ $85.00
11/2/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Boost Price TargetBuy$75.00 ➝ $89.00
10/27/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Boost Price TargetOverweight$473.00 ➝ $492.00
10/26/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Reiterated RatingSell (D-)
(Data available from 11/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elevance Health, Inc. stock logo
ELV
Elevance Health
$199.13B0.43$33.20 per share11.88$207.33 per share1.90
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$311.14M0.32$2.02 per share0.65$1.91 per share0.69
Tempus AI, Inc. stock logo
TEM
Tempus AI
$1.27B7.74N/AN/A$2.74 per share19.70
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.66B$23.4516.8213.142.132.55%14.97%5.31%1/27/2027 (Estimated)
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
-$177.97M-$2.83N/AN/AN/A-74.24%-4.84%-2.02%N/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$245.03M-$1.06N/AN/AN/A-12.54%-47.00%-9.44%N/A

Latest TEM, HCAT, and ELV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
-$0.0465-$0.03+$0.0165$0.53$55.39 million$56.28 million
11/2/2026Q3 2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.0937$0.07+$0.1637-$0.08$409.39 million$411.54 million
10/21/2026Q3 2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
$4.71$6.99+$2.28$6.27$49.28 billion$50.44 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.881.74%+12.47%29.34%14 Years
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
N/AN/AN/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
N/AN/AN/AN/AN/A

Latest TEM, HCAT, and ELV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/20/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.721.58%12/4/202612/4/202612/18/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.68
1.47
1.47
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
N/A
1.70
1.70
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.70
2.61
2.48

Institutional Ownership

CompanyInstitutional Ownership
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
85.00%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.22%

Insider Ownership

CompanyInsider Ownership
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.34%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
19.40%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
Elevance Health, Inc. stock logo
ELV
Elevance Health
97,100216.06 million215.32 millionOptionable
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1,20076.15 million61.38 millionOptionable
Tempus AI, Inc. stock logo
TEM
Tempus AI
3,800182.40 million138.15 millionOptionable

Recent News About These Companies

Tempus AI (NASDAQ:TEM) Stock: Insider Ryan Fukushima Sells 10,247 Shares
Tempus AI (NASDAQ:TEM) Stock: Insider Eric Lefkofsky Sells 17,074 Shares
Tempus AI (NASDAQ:TEM) Stock Rating Reaffirmed as "Buy" by HC Wainwright
Tempus AI (NASDAQ:TEM) EVP Sells $422,486.08 in Stock
Top Artificial Intelligence Stocks To Follow Today - November 19th
What's Going To Happen With Tempus AI Stock Soon?
Tempus AI (NASDAQ:TEM) Stock Keeps "Buy" Rating at HC Wainwright
Tempus AI: 3 Key Takeaways for Long-Term Investors
Tempus Ai, Inc. Extends Strategic Collaboration with Astrazeneca AB
Best Artificial Intelligence Stocks To Follow Now - November 18th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Elevance Health stock logo

Elevance Health NYSE:ELV

$394.40 +4.24 (+1.09%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$392.70 -1.70 (-0.43%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Health Catalyst stock logo

Health Catalyst NASDAQ:HCAT

$1.32 +0.03 (+1.94%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$1.32 0.00 (0.00%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Tempus AI stock logo

Tempus AI NASDAQ:TEM

$53.98 -5.63 (-9.45%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$55.01 +1.04 (+1.92%)
As of 11/20/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.